Personalis, Inc. (FRA:04X)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Pharma Tests and Services	50.94M
Pharma Tests and Services Growth	59.66%
Enterprise	25.36M
Enterprise Growth	-20.06%
Population Sequencing	7.43M
Population Sequencing Growth	-21.06%
Clinical Diagnostic	759.00K
Other	122.00K
Other Growth	-72.02%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
United States	81.23M
United States Growth	22.83%
International	3.38M
International Growth	-53.94%